Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro

The European Journal of Neuroscience
Mark O CunninghamRoland S G Jones

Abstract

We have recently shown that the anticonvulsant drugs phenytoin, lamotrigine and sodium valproate all reduce the release of glutamate at synapses in the entorhinal cortex in vitro. In the present investigation we determined whether this property was shared by gabapentin and pregabalin, using whole-cell patch-clamp recordings of excitatory postsynaptic currents (EPSCs) in layer V neurons in slices of rat entorhinal cortex. Both drugs reduced the amplitude and increased the paired-pulse ratio of EPSCs evoked by electrical stimulation of afferent inputs, suggesting a presynaptic effect to reduce glutamate release. The frequency of spontaneous EPSCs (sEPSCs) was concurrently reduced by GBP, further supporting a presynaptic action. There was no significant change in amplitude although a slight reduction was seen, particularly with gabapentin, which may reflect a reduction in the number of larger amplitude sEPSCs. When activity-independent miniature EPSCs were recorded in the presence of tetrodotoxin, both drugs continued to reduce the frequency of events with no change in amplitude. The reduction in frequency induced by gabapentin or pregabalin was blocked by application of the l-amino acid transporter substrate l-isoleucine. The res...Continue Reading

References

Jul 1, 1994·Epilepsia·S S Spencer, D D Spencer
Nov 15, 1993·European Journal of Pharmacology·R J ThurlowG N Woodruff
Feb 15, 1993·European Journal of Pharmacology·N Suman-ChauhanG N Woodruff
Apr 29, 1998·Epilepsy Research·C P TaylorL Singh
Jul 29, 1998·Neuropharmacology·A StefaniG Bernardi
Nov 21, 1998·The European Journal of Neuroscience·N Savić, M Sciancalepore
Aug 22, 2000·British Journal of Pharmacology·M K PatelK Lee
Sep 1, 2000·Brain Research·W P Meder, D J Dooley
Apr 18, 2001·Molecular Pharmacology·E MaraisF Hofmann
Dec 14, 2001·Neurobiology of Disease·G D'ArcangeloM Avoli
Jan 24, 2002·Neuropharmacology·Klaus FinkManfred Göthert

❮ Previous
Next ❯

Citations

Nov 13, 2008·Naunyn-Schmiedeberg's Archives of Pharmacology·B BrawekT J Feuerstein
Jan 8, 2013·European Journal of Clinical Pharmacology·Maximilian GahrCarlos Schönfeldt-Lecuona
Jul 2, 2008·Current Neurology and Neuroscience Reports·Michael A Rogawski, Carl W Bazil
Nov 8, 2012·Advances in Therapy·Riccardo GuglielmoLuigi Janiri
May 5, 2010·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Hue Jung ParkDong Eon Moon
Jan 3, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Brian S Meldrum, Michael A Rogawski
Jan 5, 2012·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Anna FörgChristian A Müller
Apr 19, 2012·British Journal of Anaesthesia·J H RyuC S Kim
Jun 28, 2012·Addiction Biology·Giordano de GuglielmoRoberto Ciccocioppo
Dec 24, 2010·The Journal of Pharmacology and Experimental Therapeutics·Mariano N Di GuilmiOsvaldo D Uchitel
May 30, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Marisa RobertoGeorge F Koob
Sep 8, 2011·Journal of Anaesthesiology, Clinical Pharmacology·Dalim Kumar BaidyaMahesh Kumar Arora
Jan 17, 2014·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Karl O NakkenErik Taubøll
Sep 3, 2011·Psychopharmacology·Serena StopponiRoberto Ciccocioppo
Jul 21, 2009·Evidence-based Complementary and Alternative Medicine : ECAM·Ruiping ZhangPiu Chan
Nov 28, 2012·Expert Opinion on Emerging Drugs·Marco Mula
Oct 8, 2013·The Journal of Pain : Official Journal of the American Pain Society·Ling DongBeth A Winkelstein
Sep 24, 2015·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Michael D PerloffDonna Kurowski
Mar 27, 2012·Neuroscience Letters·Richard E Harris, Daniel J Clauw
May 4, 2011·Pharmacology, Biochemistry, and Behavior·M Foster OliveRobert J Malcolm
Jan 16, 2007·Trends in Pharmacological Sciences·David J DooleyDouglas Feltner
Dec 21, 2006·Pain Practice : the Official Journal of World Institute of Pain·Noor M Gajraj
Oct 23, 2009·Veterinary Anaesthesia and Analgesia·Veronica SalazarJohn W Ludders
Mar 6, 2010·Annals of the New York Academy of Sciences·Bryan K YamamotoGary A Gudelsky
Feb 6, 2010·Journal of Neurochemistry·Naresh KumarTerence J Coderre
Aug 21, 2007·Biochemical Pharmacology·Justin T Gass, M Foster Olive
Oct 28, 2006·Seminars in Cell & Developmental Biology·Y P ManeufK Lee
Jul 7, 2012·Neurobiology of Disease·Huifang LiDavid A Prince
Aug 15, 2014·Expert Opinion on Therapeutic Patents·Juan-Alberto Arranz-TagarroJuan-Fernando Padín
Oct 16, 2012·Brain Research Bulletin·Carina WeissmannOsvaldo D Uchitel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.